{"id":"W4311737282","doi":"10.1093/ofid/ofac492.108","title":"1585. Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results","year":2022,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Placebo; Viral load; Internal medicine; Randomized controlled trial; Adverse effect; Human immunodeficiency virus (HIV); Gastroenterology; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001150735,0.0005760676,0.0008486498,0.0002313209,0.0002428327,0.0005025101,0.0003511389,0.0007118213,0.00770219],"category_scores_gemma":[0.001372047,0.0002032333,0.0009462243,0.0001537473,0.0001481679,0.0004918688,0.0002454998,0.0008147808,0.001989972],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003552376,"about_ca_system_score_gemma":0.0004097467,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007879483,"about_ca_topic_score_gemma":0.0009886279,"domain_scores_codex":[0.999474,0.0002217197,0.00004571279,0.00009871458,0.00007038161,0.00008947279],"domain_scores_gemma":[0.9992133,0.0001232927,0.0002464083,0.00009376092,0.0001253068,0.0001978657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5632537,0.03845393,0.06684625,0.0008558082,0.00158976,0.0002938742,0.0002229426,0.001603639,0.03873577,0.0001164481,0.009175001,0.2788528],"study_design_scores_gemma":[0.1321729,0.5447776,0.2882079,0.0002412581,0.001704708,0.0003719529,0.0001442477,0.003243007,0.01806245,0.0002595507,0.01071776,0.00009666238],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9892379,0.001346942,0.0004865462,0.0001958672,0.00006635654,0.001230302,0.002647888,0.0001247477,0.004663386],"genre_scores_gemma":[0.9902028,0.0002841756,0.0006506011,0.0003212423,0.00005680413,0.0009790843,0.001660581,0.00001836364,0.005826455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00770219,"threshold_uncertainty_score":0.02576643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01391594436879753,"score_gpt":0.2724524100668146,"score_spread":0.2585364656980171,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}